Conventional treatment of ovarian cancer

Ovarian cancer is a malignant tumor occurred in ovarian tissue. Clinically, there may be lower abdominal discomfort, abdominal pain, abdominal mass, menstrual disorder, oppression and other symptoms.

Occult ovarian cancer onset, early difficult to find, easy to transfer, characterized by poor prognosis. Accounting for about 15% of gynecologic malignancies.

The incidence of ovarian cancer common malignancy in women as a percentage of 2.4-5.6%. In the female genital tract malignancies in third place, behind cancer, cervical cancer and Palace. Carcinoma in women in the reproductive tract, ovarian cancer is the highest cause of death in a tumor.

Ovarian cancer can occur at any age.

Ovarian cancer may choose surgery, chemotherapy and radiotherapy. However, because of its pathological type of complex, qualitative, positioning the diagnosis and staging without laparoscopy or laparotomy is difficult to clear. Thus, other than cases of unresectable tumors or substantially understand the type of surgery in patients with systemic situation can not be competent, could try before chemotherapy or radiotherapy after surgery were re-consider, as appropriate, the generally preferred surgery. Surgical exploration can be further clarified the scope of tumor types and involving, clear staging, not only for surgery, chemotherapy and radiation therapy provide the basis, but as far as possible tumor resection surgery, postoperative chemotherapy or radiotherapy can also create conditions to improve the curative effect.

http://www.tcmwell.com

(A) surgical treatment of ovarian cancer surgery is the most important means of the estimated tumor can not be removed unless the clinical and surgical contraindications, should be the first surgery.

1, comprehensive staging laparotomy to determine: for the preoperative diagnosis of stage I ovarian cancer patients. Including full removal of the uterus and pairs of accessories and omental resection, pelvic and abdominal para-aortic lymphadenectomy, peritoneal cytology (ascites or pelvic, peritoneal lavage fluid).

2, cytoreductive surgery: application for more than II patients.

3, the second duct exploration: OK success cytoreductive surgery a year, has implemented at least six courses of chemotherapy, clinical examination and laboratory examinations (including the tumor marker CA125, etc.) showed no abnormality, re-laparotomy surgery.

(B) the majority of cancer radiation therapy, for a variety of radiation therapy effects are poor. Thus, in the treatment of malignant ovarian tumor was not first consider the radiation therapy. After exploratory laparotomy proved to be malignant ovarian tumor was not able to resection, viable X-ray irradiation in vitro. However, the amount of ascites were not multi-line radiotherapy.

(C) Chemical treatment of ovarian cancer are mostly better response to chemotherapy. In recent years, rapid progress in cancer chemotherapy in the treatment of ovarian cancer occupies an important position, enhancing the therapeutic effect of ovarian cancer to play an active role, can be used as surgical adjuvant therapy, commonly used in the preoperative, intraoperative and postoperative, but often require a longer period of intermittent medication, and the toxicity of the human body is sometimes greater. In most cases, surgery is difficult to ovarian cancer, the primary foci and metastases excision, especially the cultivation of small particles nodules; as well as some patients who do not want surgery, then consideration should be given chemotherapy based comprehensive treatment.






tags: Cancer ovarian